Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GIST Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01541709
What this trial is testing

Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 23
Testing effectiveness (Phase 2)Study completedNCT00005862
What this trial is testing

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00005874
What this trial is testing

Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcomaSmall Intestine Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT01323400
What this trial is testing

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
GIST
Centre Leon Berard 81
Testing effectiveness (Phase 2)Study completedNCT02880020
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Gastrointestinal Stromal Tumor
Jonsson Comprehensive Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT01440959
What this trial is testing

Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05009927
What this trial is testing

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)

Who this might be right for
Metastatic Gastrointestinal Stromal Tumor (GIST)C-KIT MutationAdvanced Gastrointestinal Stromal Tumor (GIST)
Centre Leon Berard 50
Testing effectiveness (Phase 2)Study completedNCT03609424
What this trial is testing

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 39
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Testing effectiveness (Phase 2)Study completedNCT00041249
What this trial is testing

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
European Organisation for Research and Treatment of Cancer - EORTC 64
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00030667
What this trial is testing

Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood

Who this might be right for
Childhood Desmoplastic Small Round Cell TumorChildhood Synovial SarcomaGastrointestinal Stromal Tumor+5 more
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT01089595
What this trial is testing

Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
GISTMetastatic Disease
Fox Chase Cancer Center 5
Not applicableStudy completedNCT01246843
What this trial is testing

Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib

Who this might be right for
Metastatic Renal Cell CancerGIST
Radboud University Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT00004911
What this trial is testing

Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionGastric Cancer+4 more
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00005597
What this trial is testing

S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
SWOG Cancer Research Network 25
Large-scale testing (Phase 3)Looking for participantsNCT05208047
What this trial is testing

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Who this might be right for
Advanced Gastrointestinal Stromal TumorsMetastatic Cancer
Cogent Biosciences, Inc. 482
Large-scale testing (Phase 3)Ended earlyNCT00688766
What this trial is testing

Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Infinity Pharmaceuticals, Inc. 47
Early research (Phase 1)Study completedNCT00025415
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60
Next Page